Viewing StudyNCT00324727

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 4:49 PM
Last Modification Date: 2024-10-26 @ 9:24 AM
Study NCT ID: NCT00324727
Status: COMPLETED
Last Update Posted: 2021-06-21
First Post: 2006-05-10
Brief Title: Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma
Sponsor: Delcath Systems Inc
Organization: Delcath Systems Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Metastatic Cancer
Intraocular Melanoma
Melanoma Skin
Keywords:
Name View
liver metastases View
extraocular extension melanoma View
stage IV melanoma View
recurrent melanoma View
recurrent intraocular melanoma View
metastatic intraocular melanoma View
iris melanoma View
ciliary body and choroid melanoma mediumlarge size View